Sahni, N. et al. Widespread macromolecular interaction perturbations in human genetic disorders. Cell 161, 647–660 (2015).
Article PubMed PubMed Central Google Scholar
Woodsmith, J. & Stelzl, U. Studying post-translational modifications with protein interaction networks. Curr. Opin. Struct. Biol. 24, 34–44 (2014).
Iqbal, S. et al. Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants. Proc. Natl Acad. Sci. USA 117, 28201–28211 (2020).
Article PubMed PubMed Central Google Scholar
Ardito, F., Giuliani, M., Perrone, D., Troiano, G. & Lo Muzio, L. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (review). Int. J. Mol. Med. 40, 271–280 (2017).
Article PubMed PubMed Central Google Scholar
Viéitez, C. et al. High-throughput functional characterization of protein phosphorylation sites in yeast. Nat. Biotechnol. 40, 382–390 (2022).
Bowden, A. R. et al. Parallel CRISPR–Cas9 screens clarify impacts of p53 on screen performance. eLife 9, e55325 (2020).
Article PubMed PubMed Central Google Scholar
Haapaniemi, E., Botla, S., Persson, J., Schmierer, B. & Taipale, J. CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response. Nat. Med. 24, 927–930 (2018).
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).
Article PubMed PubMed Central Google Scholar
Cuella-Martin, R. et al. Functional interrogation of DNA damage response variants with base editing screens. Cell 184, 1081–1097 (2021).
Article PubMed PubMed Central Google Scholar
Hanna, R. E. et al. Massively parallel assessment of human variants with base editor screens. Cell 184, 1064–1080 (2021).
Xu, P. et al. Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs. Nat. Biotechnol. 39, 1403–1413 (2021).
Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843–846 (2018).
Article PubMed PubMed Central Google Scholar
Zhu, S. et al. Guide RNAs with embedded barcodes boost CRISPR-pooled screens. Genome Biol. 20, 20 (2019).
Article PubMed PubMed Central Google Scholar
Bao, Y. et al. Unbiased interrogation of functional lysine residues in human proteome. Mol. Cell 83, 4614–4632 (2023).
Kolde, R., Laur, S., Adler, P. & Vilo, J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 28, 573–580 (2012).
Article PubMed PubMed Central Google Scholar
Martinez-Jimenez, F. et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer 20, 555–572 (2020).
Kano, Y. et al. Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation. Nat. Commun. 10, 224 (2019).
Article PubMed PubMed Central Google Scholar
Cirstea, I. C. et al. Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes. Hum. Mol. Genet. 22, 262–270 (2013).
Gong, J. et al. The C2 domain and altered ATP-binding loop phosphorylation at Ser359 mediate the redox-dependent increase in protein kinase C-δ activity. Mol. Cell. Biol. 35, 1727–1740 (2015).
Article PubMed PubMed Central Google Scholar
Newton, A. C. & Brognard, J. Reversing the paradigm: protein kinase C as a tumor suppressor. Trends Pharmacol. Sci. 38, 438–447 (2017).
Article PubMed PubMed Central Google Scholar
Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647–661 (2014).
Article PubMed PubMed Central Google Scholar
Dumaz, N. & Marais, R. Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J. Biol. Chem. 278, 29819–29823 (2003).
Grethe, S. & Porn-Ares, M. I. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2–ERK1/2 survival pathway in TNF-α induced endothelial apoptosis. Cell Signal 18, 531–540 (2006).
Lavoie, H., Gagnon, J. & Therrien, M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat. Rev. Mol. Cell Biol. 21, 607–632 (2020).
Ochoa, D. et al. The functional landscape of the human phosphoproteome. Nat. Biotechnol. 38, 365–373 (2020).
Ubersax, J. A. & Ferrell, J. E. Jr. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 8, 530–541 (2007).
Needham, E. J., Parker, B. L., Burykin, T., James, D. E. & Humphrey, S. J. Illuminating the dark phosphoproteome. Sci. Signal 12, eaau8645 (2019).
Martin, E. W. & Holehouse, A. S. Intrinsically disordered protein regions and phase separation: sequence determinants of assembly or lack thereof. Emerg. Top. Life Sci. 4, 307–329 (2020).
Tobin, A. B. G-protein-coupled receptor phosphorylation: where, when and by whom. Br. J. Pharmacol. 153, S167–S176 (2008).
Article PubMed PubMed Central Google Scholar
Xu, C. & Min, J. Structure and function of WD40 domain proteins. Protein Cell 2, 202–214 (2011).
Article PubMed PubMed Central Google Scholar
Chong, H., Lee, J. & Guan, K. L. Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J. 20, 3716–3727 (2001).
Article PubMed PubMed Central Google Scholar
Sundar, D. et al. Wild type p53 function in p53Y220C mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence. J. Exp. Clin. Cancer Res. 38, 103 (2019).
Article PubMed PubMed Central Google Scholar
Huang, Y. F. & Bulavin, D. V. Oncogene-mediated regulation of p53 ISGylation and functions. Oncotarget 5, 5808–5818 (2014).
Article PubMed PubMed Central Google Scholar
Liu, N., Guo, Y., Ning, S. & Duan, M. Phosphorylation regulates the binding of intrinsically disordered proteins via a flexible conformation selection mechanism. Commun. Chem. 3, 123 (2020).
留言 (0)